US Genomics Changes Name to Pathogenetix, Raises $1.3M

The company also disclosed in SEC filings that it has sold $900,000 in debt instruments as part of a $1.2 million offering.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories